Aa
Generic Baraclude (Entecavir) Tablets Launched in U.S.
http://www.ptcommunity.com/news/DailyDetail.cfm?chosen=69000
Teva Pharmaceutical Industries Ltd. has announced the launch of the generic equivalent to Baraclude (entecavir) tablets, 0.5 mg and 1.0 mg, in the U.S. Teva was the first to file, making the product eligible for 180 days of marketing exclusivity.
very good news prices should lower now
Teva Pharmaceutical Industries Ltd. has announced the launch of the generic equivalent to Baraclude (entecavir) tablets, 0.5 mg and 1.0 mg, in the U.S. Teva was the first to file, making the product eligible for 180 days of marketing exclusivity.
very good news prices should lower now
few years......but china, india and brasil already refused or revoked patent
http://www.chinabiotoday.com/articles/20130730
baraclude story
http://www.firstwordpharma.com/node/1217153#axzz3CxXrpAUY
http://www.chinabiotoday.com/articles/20130730
baraclude story
http://www.firstwordpharma.com/node/1217153#axzz3CxXrpAUY
Have an Answer?
You are reading content posted in the Hepatitis B Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
